Fursultiamine

Fursultiamine (CAS No.: 804-30-8) is a synthetic thiamine derivative within the vitamin B1 and allithiamine related small molecule class that is broadly cataloged as a biochemical and pharmacological research tool for studies of cellular metabolism, stress adaptation, and oncology relevant biology, with functional background indicating improved thiamine associated bioavailability characteristics relative to parent thiamine and experimental evidence supporting modulation of injury associated phenotypes, suppression of hypoxia induced VEGF secretion, and attenuation of mitochondrial fission, thereby positioning it in translationally oriented discovery workflows focused on metabolic regulation and microenvironment responsive signaling rather than direct clinical application; current literature level descriptions suggest mechanism level involvement in thiamine dependent enzymatic networks linked to mitochondrial energy metabolism together with downstream effects on redox and hypoxia responsive pathways, while explicit single protein target assignment and standardized pathway selectivity mapping remain limited, so it is most appropriately categorized as a pathway modulating metabolic probe used to interrogate phenotype level endpoints in cell based systems and exploratory in vivo paradigms, including models relevant to nutrient deficiency biology, degenerative joint pathology, and tumor associated processes; quantitative potency parameters such as definitive IC50 or EC50 values are not consistently established across public reports for this specific molecule, and available activity characterizations are therefore best interpreted as context dependent effects typically assessed from nanomolar to micromolar range screening windows used for vitamin derivative analogs, with exact concentrations or doses determined by assay format, exposure duration, model sensitivity, and study objectives in early stage mechanism research and compound profiling campaigns.